fda compounding semaglutide enforcement news november 2025 The announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded (Wegovy) weight-loss pill from the Congress Introduces SAFE Drugs Act

For semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), the Summaries of Product Characteristics confirm that the injection site does not significantly affect the pharmacokinetics of these medications

Its not yet known how long semaglutide dry mouth lasts

GLP-1 is an effective peptide for those seeking assistance in weight management and blood sugar control

Conclusion Heres the bottom line: Retatrutide offers exceptional weight loss potential , possibly the most powerful weve seen so far

Medications that target just GLP-1 typically aid in weight loss

Retatrutide, due to the glucagon effect in the liver, sets a new benchmark for MASLD/MASH therapy